個人化醫療市場：按應用、適應症、最終用戶和地區分類

Personalized Medicine Market, By Application, By Indication, By End User, By Geography

出版日期: 2026年03月27日 | 出版商:

Coherent Market Insights | 英文 154 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2026年，個人化醫療市場規模預計為978.9億美元，預計到2033年將達到1,883.4億美元。預計2026年至2033年，該市場將以9.8%的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	978.9億美元
歷史數據時期：	2020-2024	預測期：	2026-2033
2026年至2033年預測期間的複合年成長率：	9.80%	2033年市場規模預測：	1883.4億美元

個人化醫療旨在提供根據每位患者個體特徵量身定做的醫療保健服務，並基於基因、生物標記和臨床風險因素提供標靶治療。這標誌著治療和疾病預防方式從統一模式轉向高度客製化系統的轉變，該系統充分考慮了患者基因、環境和生活方式的個體差異。個人化醫療可望透過更明智的醫療決策，減少藥物不良反應，提高治療效果，並改善健康結果。基因檢測、巨量資料分析和分子診斷技術的進步使醫生能夠從基因層面分析患者對特定疾病的易感性，並據此最佳化治療方法。這一新興領域正在改變疾病在個體層面的診斷、治療和預防方式。

市場動態

個人化醫療市場的發展受到許多因素的驅動，例如醫療保健成本和藥物研發成本的上升、對標靶治療的需求不斷成長、伴隨診斷的重要性日益凸顯、精準醫療的關注度不斷提高以及可用於研究的基因數據日益豐富。然而，患者和醫生對這種模式的認知度較低、初始成本高昂以及監管方面的挑戰阻礙了市場成長。新興國家醫療基礎設施的建設為市場參與企業提供了巨大的成長機會。領先企業正在投資巨量資料分析，並與診斷檢測公司合作開發聯合產品，以改善患者的治療效果。預計未來十年，藥物基因體學和伴隨診斷的持續研究將進一步擴大個人化醫療的能力。

本研究的關鍵特徵

本研究確定了各細分市場的潛在收入成長機會，並說明了該市場具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據以下參數對全球個人化醫療市場的主要參與者進行了分析：公司亮點、產品系列、關鍵亮點、財務績效和策略。
透過利用本報告中的見解，企業行銷負責人和經營團隊可以就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
全球個人化醫療市場報告的目標受群眾外包括該行業的各類相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過利用全球個人化醫療市場分析中使用的各種策略矩陣來簡化決策過程。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第8章競爭情勢

公司簡介
- Precision Biologics
- Danaher Corporation
- Abbott
- Illumina, Inc.
- Exact Sciences Corporation
- ASURAGEN, INC.
- Exagen Inc.
- Genentech, Inc.
- Berg Health
- Omada Health
- Natera
- Invitae
- Myriad Genetics
- Celcuity
- InsightRX
- Axial3D

第9章分析師觀點

機會分析
一致的機會地圖

第10章：參考文獻與調查方法

參考
調查方法

簡介目錄

Product Code: CMI6807

Personalized Medicine Market is estimated to be valued at USD 97.89 Bn in 2026 and is expected to reach USD 188.34 Bn by 2033, growing at a compound annual growth rate (CAGR) of 9.8% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 97.89 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	9.80%	2033 Value Projection:	USD 188.34 Bn

Personalized medicine aims to tailor healthcare to the individual characteristics of each patient, providing targeted treatment based on genetics, biomarkers, and clinical risk factors. It represents an evolution from a one-size-fits-all approach to treatment and disease prevention to a highly customized system that considers individual variability in patients' genes, environments, and lifestyles. Personalized medicine has the potential to reduce adverse drug reactions, enhance treatment efficacy, and improve health outcomes through better-informed medical decisions. With advancements in genetic testing, big data analytics and molecular diagnostics, it enables physicians to genetically profile patients' susceptibility to specific diseases and optimize therapies accordingly. This emerging field is transforming how diseases are diagnosed, treated, and prevented on an individual level.

Market Dynamics

The personalized medicine market is driven by factors such as rising healthcare costs and drug development costs for pharmaceutical companies, increasing demand for targeted therapies, growing prominence of companion diagnostics, rising focus on precision medicine, and availability of genetic data for research. However, lack of awareness about this approach among patients and physicians, high upfront costs, and regulatory issues hinder the growth of this market. Developing healthcare infrastructure in emerging economies provides significant growth opportunities for market players. Market leaders are investing in big data analytics and collaborating with diagnostic testing companies to develop combination products for better patient outcomes. Continued research in pharmacogenomics and companion diagnostics will further expand the capabilities of personalized medicine over the next decade.

Key Features of the Study

It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global personalized medicine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study includes Precision Biologics, Danaher Corporation, Abbott, Illumina, Inc., Exact Sciences Corporation, ASURAGEN, INC., Exagen Inc., Genentech, Inc., Berg Health, Omada Health, Natera, Invitae, Myriad Genetics, Celcuity, InsightRX, and Axial3D
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global personalized medicine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global personalized medicine market

Market Segmentation

Application Insights (Revenue, USD Bn, 2021 - 2033)
Therapeutics
Diagnostics
Indication Insights (Revenue, USD Bn, 2021 - 2033)
Oncology
Immunology
Neurology
Cardiology
Autoimmune Diseases
Others
End User Insights (Revenue, USD Bn, 2021 - 2033)
Hospital & Clinics
Diagnostic Laboratories
Academic & Research Institutes
Others
Regional Insights (Revenue, USD Bn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
Precision Biologics
Danaher Corporation
Abbott
Illumina, Inc.
Exact Sciences Corporation
ASURAGEN, INC.
Exagen Inc.
Genentech, Inc.
Berg Health
Omada Health
Natera
Invitae
Myriad Genetics
Celcuity
InsightRX
Axial3D

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Application
- Market Snapshot, By Indication
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Recent Developments
Acquisitions and Partnerships Scenario
Technology Overview
Regulatory Scenario
Pricing Analysis
PEST Analysis

4. Global Personalized Medicine Market, By Application, 2021 - 2033, (USD Bn)

Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Therapeutics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Diagnostics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

5. Global Personalized Medicine Market, By Indication, 2021 - 2033, (USD Bn)

Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Oncology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Immunology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Neurology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Cardiology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Autoimmune Diseases
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

6. Global Personalized Medicine Market, By End User, 2021 - 2033, (USD Bn)

Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Hospital & Clinics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Diagnostic Laboratories
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Academic & Research Institutes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

7. Global Personalized Medicine Market, By Region, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021 - 2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

8. Competitive Landscape

Company Profiles
- Precision Biologics
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Danaher Corporation
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Abbott
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Illumina, Inc.
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Exact Sciences Corporation
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- ASURAGEN, INC.
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Exagen Inc.
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Genentech, Inc.
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Berg Health
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Omada Health
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Natera
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Invitae
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Myriad Genetics
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Celcuity
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- InsightRX
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Axial3D
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies